选择性排除患者对早产预测测试性能的影响
本文指出早产预测生物标志物研究中,选择性排除定义边界附近患者会虚高测试性能。基于美国一项蛋白质组学临床试验数据,同一测试的受试者工作特征曲线下面积从0.68(<37周早产)或0.76(<32周早产)虚高至0.91(排除晚期早产患者)。作者建议向临床医生和研究者传达适用于全部目标人群的性能。
要点
- 预测早产测试应报告全部目标人群的性能,而非选择性排除患者。
- 排除晚期早产患者可使同一测试AUC从0.68或0.76虚高至0.91。
- 选择性排除患者会导致报告的性能不准确,需规范实验设计与数据分析报告。
核心结论
- 开发预测测试时必须报告所有临床适用患者(即目标使用人群)的性能,早产预测应涵盖整个孕周谱系的分娩患者。
研究设计与样本
- 本文为评论文章,基于美国一项名为「蛋白质组学评估早产风险」的临床试验所收集的生物标志物数据提供示例。
主要发现
- 同一测试的受试者工作特征曲线下面积(AUC)在早产<37周时为0.68,在早产<32周时为0.76,当排除晚期早产患者后虚高至0.91。
关键数值与推荐
- 预测早产测试的性能应报告所有目标使用人群,包括整个孕周谱系的分娩患者。
临床怎么用
- 作者建议临床医生和研究者今后应报告适用于全部目标人群的测试性能,避免选择性排除患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The need to reduce the rate of preterm delivery and the recent emergence of technologies that measure hundreds of biological analytes (eg, genomics, transcriptomics, metabolomics, proteomics; collectively referred to as "omics approaches") have led to proliferation of potential diagnostic biomarkers. On review of the literature, a concern must be raised regarding experimental design and data analysis reporting. Specifically, inaccurate performance has often been reported after selective exclusion of patients around the definition boundary of preterm birth. For example, authors may report the performance of a preterm delivery predictor by using patients who delivered early preterm compared with deliveries at 37 weeks of gestation or greater. A key principle that must be maintained during the development of any predictive test is to communicate performance for all patients for whom the test will be applicable clinically (ie, the intended-use population), which for prediction of preterm birth includes patients delivering throughout the spectrum of gestational ages, as this is what is to be predicted, and not known at the time of testing. Using biomarker data collected from the U.S.-based Proteomic Assessment of Preterm Risk clinical trial, we provide examples where the area under the receiver operating characteristic curve for the same test artifactually improves from 0.68 (for preterm delivery at less than 37 weeks of gestation) or 0.76 (for preterm delivery at less than 32 weeks of gestation) to 0.91 when patients who deliver late preterm are excluded. We review this phenomenon in this commentary and offer recommendations for clinicians and investigators going forward. FUNDING SOURCE:: Sera Prognostics.
引用
- Boniface JJ, Burchard J, Saade GR, et al. Effects of Selective Exclusion of Patients on Preterm Birth Test Performance. Obstet Gynecol. 2019. PMID: 31764747. doi:10.1097/AOG.0000000000003511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。